about
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. T...
Read More
21.89
1.09
(5.24%)
95,212
XNAS Volume
XNAS 17 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for Nanobiotix - ADR is on 19 Nov 2025 for the purpose of Nanobiotix SA Third Quarter Earnings Result for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Nanobiotix ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..